Top

UP Covid see slight dip, reports 17,775 new cases; Lucknow tops tally with 856 cases

On Thurday, 17,775 new coronavirus cases have been found in the state.

Shivani

ShivaniBy Shivani

Published on 13 May 2021 12:42 PM GMT

UP Covid see slight dip, reports 17,775 new cases; Lucknow tops tally with 856 cases
X

CORONA UPDATES (PC: Social Media)

  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print

LUCKNOW: The second wave of COVID 19 has proven to be harmful and fatal. The state on Tuesday reported 17,775 fresh cases with 281 fatalities. While 19,425 people are discharged in Uttar Pradesh in the past 24 hours.

In, most popular city Lucknow, 856 new coronavirus cases were found. While 2,432 recovered.

Panic in UP:

Most shocking things are happening in Uttar Pradesh and Bihar. As multiple bodies were found buried in sand in at least two locations along the Ganga river in Uttar Pradesh's Unnao district on Wednesday

Additional Chief Secretary, Health, Amit Mohan Prasad said that following the "track, test and treat" policy, surveillance teams of the state government have reached 3.47 crore households, covering a total of 16.73 crore people. Prasad said while 1.11 crore people have been administered the first dose of COVID-19 vaccine, 29.35 lakh have received the second shot.

The programme of vaccinating people in the 18-44 age group is also going on in the state and so far 2.16 lakh in this category have been administered vaccines, he said.

Meanwhile, Fourteen doctors working at community and primary health centres in Uttar Pradesh's Unnao have tendered their resignation alleging misbehaviour and mental harassment by administration officers.

COVID in India:

India sees a slight increase in new figures of coronavirus infection. In the last 24 hours, a total of 3 lakh 62 thousand 389 new cases have been registered in the country. At the same time, number of death from Covid-19 in the country remain above four lakh.

Meanwhile, The Drugs Controller General of India (DCGI) has approved the second / third phase clinical trial of COVAXIN in the age group of 2 to 18 years. Now India will conduct trials on Biotech 525 Health Volunteers. In this trial, two doses will be given to Volunteers at intervals of 0 to 28 days.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.

Shivani

Shivani

Next Story